Press Release Ernexa Therapeutics Appoints Accomplished Biopharmaceutical Executive Robert J. Spiegel, M.D., FACP, to Board of Directors Sep 17
Press Release Ernexa Therapeutics Reports Positive Disease Modifying ERNA-201 Preclinical Data, Reinforcing iMSC Platform as Company Accelerates Oncology Strategy and ERNA-101 Toward First-in-Human Dosing Sep 15
Press Release Ernexa Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference Sep 14